A subsidiary of medical device manufacturer Guidant Corp. is ending production of an aortic abdominal graft, only days after the unit pleaded guilty to criminal charges for covering up problems involving the product that may have led to 12 deaths. Endovascular Technologies pleaded guilty to 10 felonies last week, including shipping misbranded products and making false statements to government regulators.
June 17, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
AMENDED NOTICE OF BANKRUPTCY JUDGE VACANCIES DISTRICT OF UTAH The United States Court of Appeals for the Tenth Circuit seeks applicati...
The New Jersey State Commission of Investigation (SCI) is seeking an experienced and visionary leader to serve as its next Executive Directo...
We are a boutique firm specializing the area of real estate law and handling both litigation and transactional matters. We are seeking an as...